BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Pall Corporation Introduce Stax mAx Clarification Platform

Product News

New Stax™ mAx clarification platform from Pall Life Sciences delivers robust, accelerated performance across multiple mAb processes.

READ MORE

Easy-to-use, Easy-to-Choose DNA Purification Kits

Product News

Chromatrap, a leading developer of cutting-edge life science products, has launched an affordable, easy-to-use range of DNA kits for routine molecular biology applications.

READ MORE

ATCC Develops Novel in vitro Model to Investigate Drug Candidates for Cancer Metastasis

Product News

ATCC have announced the release of an innovative, in vitro model system for a key mechanism of invasion and metastasis in lung cancer.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE